Press releases
You will be able to find all of our recent and archived news announcements. Our press releases are intended for business journalists.
GSK’s Mississauga manufacturing operations undergoes $36 M modernization; Site to produce leading topical pain reliever, VOLTAREN
National Advisory Committee on Immunization (NACI) recommends SHINGRIX for the prevention of shingles for adults aged 50 and up
GSK and NEOMED call for proposals for innovative early stage human therapeutic projects in Quebec
Quebec’s Committee on Immunization (CIQ) recommends preferential use of SHINGRIX for the prevention of shingles in adults aged 50 and up
TRELEGY ELLIPTA approved in Canada as the first single inhaler triple therapy for the treatment of appropriate patients with COPD
GSK Statement: GSK Voluntary Recall of VENTOLIN DISKUS Lot 786G in Canada
Read more - GSK Statement: GSK Voluntary Recall of VENTOLIN DISKUS Lot 786G in Canada Read more
SHINGRIX approved in Canada as the first non-live adjuvanted vaccine to help protect against shingles
GSK and NEOMED Launch $2M Discovery Fund to Accelerate Novel Science and Technologies in Quebec
GSK Renews its Contribution to CQDM to Sustain Innovation in Quebec and Canada
Read more - GSK Renews its Contribution to CQDM to Sustain Innovation in Quebec and Canada Read more